ClinVar Miner

Submissions for variant NM_054012.4(ASS1):c.53C>T (p.Ser18Leu)

gnomAD frequency: 0.00001  dbSNP: rs121908643
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Baylor Genetics RCV000006703 SCV001163216 likely pathogenic Citrullinemia type I criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV002512847 SCV003441465 pathogenic Citrullinemia 2024-01-16 criteria provided, single submitter clinical testing This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 18 of the ASS1 protein (p.Ser18Leu). This variant is present in population databases (rs121908643, gnomAD 0.006%). This missense change has been observed in individual(s) with clinical features of ASS1-related conditions (PMID: 1943692, 31208364; Invitae). ClinVar contains an entry for this variant (Variation ID: 6331). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ASS1 protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic.
OMIM RCV000006703 SCV000026894 pathogenic Citrullinemia type I 1991-02-01 no assertion criteria provided literature only
Counsyl RCV000006703 SCV000800552 uncertain significance Citrullinemia type I 2017-06-13 flagged submission clinical testing
PreventionGenetics, part of Exact Sciences RCV004755716 SCV005363534 likely pathogenic ASS1-related disorder 2024-05-23 no assertion criteria provided clinical testing The ASS1 c.53C>T variant is predicted to result in the amino acid substitution p.Ser18Leu. This variant was reported in the compound heterozygous state in individuals with citrullinemia (Kobayashi et al. 1991. PubMed ID: 1943692; Lin et al. 2019. PubMed ID: 31208364). This variant is reported in 0.0054% of alleles in individuals of East Asian descent in gnomAD and is interpreted as pathogenic or likely pathogenic by most of the submitters in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/6331/). This variant is interpreted as likely pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.